BioXcel Therapeutics Inc (FRA:BX2)
€ 1.892 0.006 (0.32%) Market Cap: 72.49 Mil Enterprise Value: 98.09 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 21/100

BioXcel Therapeutics Inc To Host Neuroscience R&D Day Transcript

Dec 12, 2023 / 06:00PM GMT
Release Date Price: €2.89 (-5.11%)
Operator

Greetings, and welcome to the BioXcel Therapeutics Neuroscience R&D Day. At this time, I'd like to turn the call over to Dr. Frank Yocca of BioXcel. Thank you, you may begin.

Frank Yocca BioXcel Therapeutics Inc;Chief Scientific Officer

Thank you, operator. Good afternoon, everyone. I'm Frank Yocca, Chief Science Officer at BioXcel Therapeutics. Thank you for joining our virtual Neuroscience R&D Day.

As a reminder, during today's presentation, we will be making forward-looking statements regarding our R&D plans. These statements are subject to risks and uncertainties that may cause actual results to materially differ from those forecast. The risk factors that may affect results are detailed in our most recent public filings with the SEC, including our most recent Form 10-Q on file with the SEC and available on our website.

Next slide, please.

It's been two years since we last hosted an R&D presentation for our neuroscience franchise emerging pipeline. And today we are very pleased to share with you several

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot